| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
Correspondence: Hyun-Ki Yoon, MD, Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap-2-Dong, Songpa-Ku, Seoul, 138-736, Korea. E-mail: hkyoon{at}amc.seoul.kr
This study evaluates the efficacy of percutaneous transluminal balloon angioplasty (PTA) to treat stenosis or occlusion following haemostasis using a suture-mediated closure (SMC) device. Steno-occlusion occurred in 7 (0.4%) patients, some with claudication, others without. Steno-occlusion was diagnosed immediately after haemostasis in the four patients without claudication, but diagnosis was delayed in all three patients with claudication. Six of the patients subsequently underwent PTA using a contralateral femoral arterial approach. Technical success, clinical response and vessel patency were evaluated retrospectively. Follow-up angiography revealed focal segmental steno-occlusion (<1 cm) in the common femoral or proximal superficial femoral artery in four patients and long segmental occlusion (>1 cm) in the external iliac and common femoral arteries in three patients. PTA was technically successful in all patients (6/6, 100%). Among the three patients who developed delayed onset of claudication, one declined treatment and the claudication improved in two. Doppler ultrasound obtained 28–129 days (mean; 75 days) after PTA revealed patent arterial flow in six patients. One patient with delayed-onset occlusion refused the procedure because the symptoms were mild. This study has shown that PTA is a useful treatment for steno-occlusion following haemostasis using the SMC device. Careful angiography and review of the femoral bifurcation prior to use of an SMC device is important.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |